Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1032 | 2803 | 39.8 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
233 | 19645 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GRAFT VERSUS HOST DISEASE | Author keyword | 105 | 20% | 16% | 461 |
2 | CHRONIC GRAFT VERSUS HOST DISEASE | Author keyword | 74 | 46% | 4% | 122 |
3 | GVHD | Author keyword | 55 | 22% | 8% | 219 |
4 | ACUTE GVHD | Author keyword | 53 | 52% | 3% | 72 |
5 | ACUTE GRAFT VERSUS HOST DISEASE | Author keyword | 52 | 42% | 3% | 94 |
6 | CHRONIC GVHD | Author keyword | 36 | 41% | 2% | 68 |
7 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | Journal | 32 | 11% | 10% | 280 |
8 | NIH CONSENSUS CRITERIA | Author keyword | 21 | 90% | 0% | 9 |
9 | INTESTINAL GVHD | Author keyword | 15 | 88% | 0% | 7 |
10 | CGVHD | Author keyword | 14 | 55% | 1% | 18 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GRAFT VERSUS HOST DISEASE | 105 | 20% | 16% | 461 | Search GRAFT+VERSUS+HOST+DISEASE | Search GRAFT+VERSUS+HOST+DISEASE |
2 | CHRONIC GRAFT VERSUS HOST DISEASE | 74 | 46% | 4% | 122 | Search CHRONIC+GRAFT+VERSUS+HOST+DISEASE | Search CHRONIC+GRAFT+VERSUS+HOST+DISEASE |
3 | GVHD | 55 | 22% | 8% | 219 | Search GVHD | Search GVHD |
4 | ACUTE GVHD | 53 | 52% | 3% | 72 | Search ACUTE+GVHD | Search ACUTE+GVHD |
5 | ACUTE GRAFT VERSUS HOST DISEASE | 52 | 42% | 3% | 94 | Search ACUTE+GRAFT+VERSUS+HOST+DISEASE | Search ACUTE+GRAFT+VERSUS+HOST+DISEASE |
6 | CHRONIC GVHD | 36 | 41% | 2% | 68 | Search CHRONIC+GVHD | Search CHRONIC+GVHD |
7 | NIH CONSENSUS CRITERIA | 21 | 90% | 0% | 9 | Search NIH+CONSENSUS+CRITERIA | Search NIH+CONSENSUS+CRITERIA |
8 | INTESTINAL GVHD | 15 | 88% | 0% | 7 | Search INTESTINAL+GVHD | Search INTESTINAL+GVHD |
9 | CGVHD | 14 | 55% | 1% | 18 | Search CGVHD | Search CGVHD |
10 | ORAL CHRONIC GRAFT VERSUS HOST DISEASE | 11 | 100% | 0% | 6 | Search ORAL+CHRONIC+GRAFT+VERSUS+HOST+DISEASE | Search ORAL+CHRONIC+GRAFT+VERSUS+HOST+DISEASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CONSENSUS DEVELOPMENT PROJECT | 161 | 63% | 6% | 163 |
2 | WORKING GROUP REPORT | 111 | 50% | 6% | 160 |
3 | ACUTE GVHD | 103 | 44% | 6% | 178 |
4 | CHRONIC GVHD | 73 | 49% | 4% | 108 |
5 | REFRACTORY CHRONIC GVHD | 42 | 83% | 1% | 24 |
6 | MOUSE RADIATION CHIMERAS | 41 | 81% | 1% | 25 |
7 | GVHD | 34 | 27% | 4% | 106 |
8 | INTESTINAL GRAFT | 33 | 66% | 1% | 31 |
9 | COMPARING METHOTREXATE | 27 | 43% | 2% | 48 |
10 | SECONDARY DISEASE | 23 | 70% | 1% | 19 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 32 | 11% | 10% | 280 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | 2005 | 1080 | 27 | 74% |
Graft-versus-host disease | 2009 | 528 | 128 | 45% |
Current issues in chronic graft-versus-host disease | 2014 | 18 | 85 | 75% |
Advances in graft-versus-host disease biology and therapy | 2012 | 149 | 161 | 43% |
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation | 2012 | 56 | 47 | 96% |
How we treat chronic graft-versus-host disease | 2015 | 1 | 59 | 69% |
Graft-versus-host disease | 2007 | 300 | 136 | 35% |
Discovery and validation of graft-versus-host disease biomarkers | 2013 | 28 | 81 | 43% |
Graft-versus-host disease: why have we not made more progress? | 2014 | 8 | 54 | 74% |
Concise Review: Acute Graft-Versus-Host Disease: Immunobiology, Prevention, and Treatment | 2013 | 20 | 89 | 51% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AVDELING PATOL | 8 | 100% | 0.2% | 5 |
2 | GRAFT VERSUS HOST AUTOIMMUN UNIT | 7 | 64% | 0.2% | 7 |
3 | BLOOD MARROW TRANSPLANTAT PROGRAM | 6 | 18% | 1.1% | 31 |
4 | BLOOD MARROW TRANSPLANT PROGRAM | 6 | 10% | 1.9% | 53 |
5 | HEMATOL STEM CELL TRANSPLANT PROGRAM | 5 | 63% | 0.2% | 5 |
6 | BIOMETADYS EA4273 | 4 | 67% | 0.1% | 4 |
7 | EXPT TRANSPLANTAT IMMUNOL BRANCH | 4 | 10% | 1.4% | 39 |
8 | UAM ALLOGREFFES CSH | 3 | 50% | 0.1% | 4 |
9 | SERV HEMATOL GREFFE | 2 | 17% | 0.5% | 13 |
10 | ALLOGENE BLOOD MARROW TRANSPLANT PROGRAM | 2 | 32% | 0.2% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000177556 | CHRONIC GRAFT VERSUS HOST REACTION//HAROLD TANENBAUM SUITE 435 600 UNIV AVE//TH 2 CYTOKINE |
2 | 0.0000163698 | EXTRACORPOREAL PHOTOCHEMOTHERAPY//PHOTOPHERESIS//EXTRACORPOREAL PHOTOPHERESIS |
3 | 0.0000155750 | ENGRAFTMENT SYNDROME//AUTOLOGOUS GRAFT VERSUS HOST DISEASE//AUTOLOGOUS GVHD |
4 | 0.0000151247 | REDUCED INTENSITY CONDITIONING//DONOR LYMPHOCYTE INFUSION//REDUCED INTENSITY |
5 | 0.0000150163 | MINOR HISTOCOMPATIBILITY ANTIGENS//MINOR HISTOCOMPATIBILITY ANTIGEN//HA 1 |
6 | 0.0000133186 | IDIOPATHIC PNEUMONIA SYNDROME//BRONCHIOLITIS OBLITERANS//LATE ONSET NONINFECTIOUS PULMONARY COMPLICATIONS |
7 | 0.0000126724 | HAPLOIDENTICAL//NORMAL DONORS//T CELL DEPLETION |
8 | 0.0000115083 | SEPTIC INFARCTION//ASPERGILLUS BRAIN ABSCESS//CD8CD57 CELLS |
9 | 0.0000112809 | LYMPHOCYTE RECOVERY//IMMUNE RECONSTITUTION//BMT RECIPIENTS |
10 | 0.0000099896 | GENITAL GVHD//CARDIAC LATE EFFECTS//HCT HEMATOPOIETIC CELL TRANSPLANTATION |